human chronic myeloid leukemia cml cell line k562 (ATCC)
Structured Review
Human Chronic Myeloid Leukemia Cml Cell Line K562, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 11118 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+k562+cells/K-562/pm42958942-107-6-18
Average 99 stars, based on 11118 article reviews
Images
Related Articles
Cell Culture:Article Title: GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial Article Snippet: Experiments were conducted with human NK cells primed overnight with recombinant human interleukine‐15 (IL‐15) (50 ng/mL) (Sigma) in RPMI‐1640 complete medium supplemented with 10% Foetal Bovine Serum (FBS) to ensure their proper expression of human NK cells activating receptors and functionality. .. Cytokine‐activated human NK cells were cultured in the presence of Article Title: Histone H3K27 methylation states are sequentially catalyzed in cycling cells Article Snippet: .. Article Title: Spatial mapping of RNA turnover kinetics and regulatory landscapes of mRNA stability in the mammalian brain Article Snippet: .. Article Title: Highly sensitive and scalable time-resolved RNA sequencing in single cells with scNT-seq2 Article Snippet: .. Article Title: CoCUT&Tag maps linked chromatin states at single-molecule, single-cell resolution Article Snippet: .. Article Title: Chromatin-bound U2AF2 splicing factor ensures exon inclusion. Article Snippet: Human K562 cells (ATCC, Manassas, VA, Catalog #CCL-243) were cultured following the supplier’s protocol. .. Positive Control:Article Title: GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial Article Snippet: Experiments were conducted with human NK cells primed overnight with recombinant human interleukine‐15 (IL‐15) (50 ng/mL) (Sigma) in RPMI‐1640 complete medium supplemented with 10% Foetal Bovine Serum (FBS) to ensure their proper expression of human NK cells activating receptors and functionality. .. Cytokine‐activated human NK cells were cultured in the presence of Control:Article Title: GMP‐Compliant Process for the Manufacturing of an Extracellular Vesicles‐Enriched Secretome Product Derived From Cardiovascular Progenitor Cells Suitable for a Phase I Clinical Trial Article Snippet: Experiments were conducted with human NK cells primed overnight with recombinant human interleukine‐15 (IL‐15) (50 ng/mL) (Sigma) in RPMI‐1640 complete medium supplemented with 10% Foetal Bovine Serum (FBS) to ensure their proper expression of human NK cells activating receptors and functionality. .. Cytokine‐activated human NK cells were cultured in the presence of |


